» Articles » PMID: 12620753

Apolipoproteins Versus Lipids As Indices of Coronary Risk and As Targets for Statin Treatment

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2003 Mar 7
PMID 12620753
Citations 73
Authors
Affiliations
Soon will be listed here.
Citing Articles

Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.


Clinical Relevance of Nuclear Magnetic Resonance LipoProfile.

Emeasoba E, Ibeson E, Nwosu I, Montemarano N, Shani J, Shetty V Front Nucl Med. 2024; 2:960522.

PMID: 39354981 PMC: 11440956. DOI: 10.3389/fnume.2022.960522.


Association of cerebrospinal fluid NPY with peripheral ApoA: a moderation effect of BMI.

Zhao D, Han X, Mu Q, Wu Y, Shan L, Su L Nutr Metab (Lond). 2024; 21(1):52.

PMID: 39054540 PMC: 11270855. DOI: 10.1186/s12986-024-00828-6.


A potentially underestimated predictor of coronary artery disease risk: The ApoB/ApoA1 ratio.

Li B, Zhao X, Ding Y, Zhang Y Heliyon. 2024; 10(11):e32084.

PMID: 38873661 PMC: 11170140. DOI: 10.1016/j.heliyon.2024.e32084.


Exploring Possible Links: Thigh Muscle Mass, Apolipoproteins, and Glucose Metabolism in Peripheral Artery Disease-Insights from a Pilot Sub-Study following Endovascular Treatment.

Ikeda T, Komiyama H, Miyakuni T, Takano M, Asai K Metabolites. 2024; 14(4).

PMID: 38668320 PMC: 11052193. DOI: 10.3390/metabo14040192.